1. Home
  2. SIMO vs MYGN Comparison

SIMO vs MYGN Comparison

Compare SIMO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

N/A

Current Price

$84.62

Market Cap

3.2B

Sector

Technology

ML Signal

N/A

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$7.02

Market Cap

625.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIMO
MYGN
Founded
1995
1991
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
625.5M
IPO Year
2005
1995

Fundamental Metrics

Financial Performance
Metric
SIMO
MYGN
Price
$84.62
$7.02
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$103.13
$11.82
AVG Volume (30 Days)
331.7K
1.0M
Earning Date
02-04-2026
11-03-2025
Dividend Yield
2.34%
N/A
EPS Growth
8.75
N/A
EPS
2.87
N/A
Revenue
$798,326,000.00
$825,300,000.00
Revenue This Year
$10.15
$0.10
Revenue Next Year
$17.72
$5.28
P/E Ratio
$29.79
N/A
Revenue Growth
N/A
0.21
52 Week Low
$37.21
$3.76
52 Week High
$106.60
$15.47

Technical Indicators

Market Signals
Indicator
SIMO
MYGN
Relative Strength Index (RSI) 38.86 46.44
Support Level $86.56 $7.15
Resistance Level $96.77 $7.43
Average True Range (ATR) 3.13 0.28
MACD -0.41 -0.03
Stochastic Oscillator 8.64 21.20

Price Performance

Historical Comparison
SIMO
MYGN

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: